Parving, Hans Henrik

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine

Erythropoietin and Anemia TreatmentDialysis and Renal Disease Management

Cited by 2,096

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-PROTECT 2): A randomised placebo-controlled trial

Sjølie, A. K., Klein, R., Porta, M., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Chaturvedi, N. (2008) · The Lancet

Retinal Diseases and TreatmentsChronic Kidney Disease and Diabetes

Cited by 435

Comparison of different measures of urinary protein excretion for prediction of renal events

Lambers Heerspink, H. J., Gansevoort, R. T., Brenner, B. M., Cooper, M. E., Parving, H. H., Shahinfar, S., & de Zeeuw, D. (2010) · Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 193